Nextech

Nextech is an independent provider of HVAC/R services based in Melbourne, Florida, with over 30 years of experience in the industry. The company specializes in heating, ventilation, air conditioning, and refrigeration solutions tailored for commercial, industrial, retail, and hospitality sectors. Nextech is committed to delivering high-quality service and value, establishing long-term relationships with its clients through a focus on integrity and customer satisfaction. The company offers nationwide coverage and 24/7 support, ensuring that its clients can effectively manage and service their heating and cooling needs across multiple sites. By leveraging exclusive technology and a dedicated support team, Nextech helps clients optimize their budgets while fulfilling their HVAC/R requirements efficiently.

Bob Bull

President and Co-Owner

Joseph John Gelp

CEO

6 past transactions

Alumis

Series C in 2024
Alumis is a clinical-stage biopharmaceutical company dedicated to developing precision medicines for autoimmune disorders. By leveraging a proprietary data analytics platform and biological insights, Alumis aims to transform the treatment landscape for patients suffering from these conditions. The company focuses on identifying and advancing therapeutics based on genetically validated targets, which enables the creation of targeted therapies that significantly improve patient outcomes. With a team of experts experienced in drug discovery and immunology, Alumis seeks to replace broad immunosuppression with more effective, targeted treatment options, ultimately enhancing the quality of life for individuals affected by autoimmune diseases.

Aire Rite

Acquisition in 2023
Aire Rite is a company that specializes in the maintenance and installation of heating, ventilation, and air conditioning (HVAC) systems, as well as refrigeration and cooking equipment. Serving both residential and commercial customers in Southern California, Aire Rite provides comprehensive services including building automation, ice machine maintenance, and food machinery repairs. The company's focus is on enhancing energy efficiency and helping clients reduce costs associated with their equipment and systems. Through its diverse offerings, Aire Rite addresses a wide range of needs for various projects in the region.

CMI Mechanical HVAC and Refrigeration

Acquisition in 2022
CMI Mechanical is a commercial HVAC and refrigeration industry company. It is reinventing how commercial heating and cooling, and mechanical services are provided. It is specialized in boilers, chillers, cooling towers, commercial hvac services, commercial refrigeration, commercial hvac installations, and others.

Arctic Services

Acquisition in 2021
Arctic Services supplies commercial refrigeration and air conditioning equipment. They provide cold room installations, maintenance, repair services, racking systems, and mezzanine flooring services. They install, maintain, and repair refrigeration, air conditioning, and ventilation systems. Their products include counter refrigeration and multi-deck display fridges.

Patriot Mechanical

Acquisition in 2021
Patriot Mechanical has been providing Southern Maine with HVAC repair and maintenance services, such as heating, air conditioning, plumbing, and refrigeration in commercial and residential applications since 2007. We believe in passing our overhead savings on to the customer, working with our customers to stay within their budgets. With an average staff experience of 15 years, you can be reassured that the tech who arrives to perform service for you is reliable and will get the job done the first time.

ORIC Pharmaceuticals

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies to combat cancer by overcoming resistance mechanisms. The company's lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which plays a significant role in resistance to various cancer treatments across multiple solid tumors. Another key candidate, ORIC-533, is an orally bioavailable inhibitor of CD73, targeting a critical pathway in the adenosine metabolism that contributes to resistance against chemotherapy and immunotherapy. Additionally, ORIC is working on a pipeline of precision medicines aimed at addressing other cancer resistance mechanisms. Founded in 2014 and headquartered in South San Francisco, California, ORIC Pharmaceuticals leverages the expertise of its scientific founders, who have extensive backgrounds in cancer research and target discovery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.